Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
20ND02 by HK inno.N for Glaucoma: Likelihood of Approval
20ND02 is under clinical development by HK inno.N and currently in Phase II for Glaucoma. According to GlobalData, Phase II...
20ND02 by HK inno.N for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
20ND02 is under clinical development by HK inno.N and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
INC-036 by HK inno.N for Hypertension: Likelihood of Approval
INC-036 is under clinical development by HK inno.N and currently in Phase III for Hypertension. According to GlobalData, Phase III...
IN-M00001 by HK inno.N for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
IN-M00001 is under clinical development by HK inno.N and currently in Phase I for Reflux Esophagitis (Gastroesophageal Reflux Disease). According...
IN-115314 by HK inno.N for Rheumatoid Arthritis: Likelihood of Approval
IN-115314 is under clinical development by HK inno.N and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...
INC-005 by HK inno.N for Helicobacter pylori Infections: Likelihood of Approval
INC-005 is under clinical development by HK inno.N and currently in Phase II for Helicobacter pylori Infections. According to GlobalData,...
CJ-15314 by HK inno.N for Rheumatoid Arthritis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...
CJ-15314 by HK inno.N for Psoriasis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Psoriasis. According to GlobalData, Phase I...